Application of MANF protein

A protein, Sjögren's syndrome technology, applied in the field of biotechnology and medicine, can solve the problem that there is no research report on MANF protein

Active Publication Date: 2020-12-29
ANHUI MEDICAL UNIV
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no research report on the a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of MANF protein
  • Application of MANF protein
  • Application of MANF protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] This embodiment provides the application of a MANF protein in the preparation of drugs for the treatment of Sjogren's syndrome, wherein Sjögren's syndrome in this embodiment includes one of primary Sjögren's syndrome or secondary Sjögren's syndrome, and this embodiment The MANF protein is encoded by the astrocyte-derived neurotrophic factor gene.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biotechnology and medicines, discloses an application of MANF protein in preparation of a medicine for treating sicca syndrome. The application of the MANF protein in preparation of the medicine for treating the sicca syndrome is creatively provided, so that autoimmune diseases including primary sicca syndrome or secondary sicca syndrome can be treated; and the MANF protein has good clinical application prospects and can achieve obvious social benefits.

Description

technical field [0001] The invention belongs to the fields of biotechnology and medicine, and in particular relates to the application of a MANF protein in the preparation of medicines for treating Sjögren's syndrome. Background technique [0002] Sjogren's syndrome (SS) is an autoimmune disease that mainly affects the salivary glands and lacrimal glands, manifested as dry mouth and eyes; it can also affect other organs such as the skin with multi-system changes; a large number of lymph nodes can be seen in the affected organs Cell infiltration, a variety of autoantibodies can be detected in the serum, often accompanied by hyperimmunoglobulinemia. According to the cause of the disease, Sjogren's syndrome can be divided into two types: primary and secondary: primary Sjögren's syndrome is not associated with other connective tissue diseases; Sjögren's syndrome based on connective tissue diseases such as systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/18A61P37/02
CPCA61K38/185A61P37/02
Inventor 吴华勋魏伟周彤彤黄磊
Owner ANHUI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products